A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas
Claes Tropé, Janne Kærn, Ignace Vergote, Svein VossliVolume:
26
Year:
1990
Language:
english
Pages:
1
DOI:
10.1007/bf00685418
File:
PDF, 246 KB
english, 1990